-
Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...
-
Powell MR, Brown AW, Klunk D, Geske JR, Krishnan K, Green C, Bergquist TF. Injury Severity and Depressive Symptoms in a Post-acute Brain Injury ...
-
Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...
-
Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...
-
Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...
-
Bhagra, Anjali M.D., M.B.A.. Minnesota. Chesak, Sherry S. Ph.D., M.S., R.N.. Minnesota. Croghan, Ivana T. Ph.D. Minnesota. Jowsey-Gregoire, Sheila G. M.D..
-
Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...
-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
-
The purpose of this study is to describe cerebral and retinal vasoreactivity in patients with cerebral small vessel disease (SVD) vs. healthy control, to ...
-
A 4-Week Study Of The Safety, Efficacy, And Pharmacokinetics Of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] In Subjects With Parkinson's Disease ...